Research updates from Luvaminos
Subscribe for catalog updates, new research compounds, and quality documentation releases.
For researchers and labs. No spam — unsubscribe anytime.
Research updates from Luvaminos
Subscribe for catalog updates, new research compounds, and quality documentation releases.
For researchers and labs. No spam — unsubscribe anytime.
Research Category
6 compounds in the cognitive category, each documented with third-party testing and a Certificate of Analysis. For research use only.
A synthetic heptapeptide corresponding to the ACTH(4-7) core sequence with a C-terminal Pro-Gly-Pro extension.
View research referenceA synthetic heptapeptide analog of tuftsin examined in preclinical neuropharmacology, gene-expression, and neuroimmune signaling research models.
View research referenceA synthetic 9-residue peptide built on the ACTH(4–10) fragment scaffold with an adamantyl modification, studied in preclinical neuroscience research.
View research referenceAn N-terminally acetylated, C-terminally amidated synthetic heptapeptide analog of Semax, retaining the ACTH(4–7) core sequence with a Pro-Gly-Pro C-terminal extension.
View research referenceA synthetic tripeptide bioregulator studied in neurological and gene-expression research.
View research referenceA research-use-only two-component blend of two synthetic heptapeptides, each a short N-terminal sequence extended with a C-terminal Pro-Gly-Pro (glyproline) tripeptide that confers protease resistance.
View research referenceThese products are intended for research purposes only and are not for human consumption. Not FDA approved. Not intended to diagnose, treat, cure, or prevent any disease. For educational and research purposes only; not medical advice.